Celon Pharma S.A. (WSE:CLN)

Celon Pharma Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 24, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1,066	1,096	1,425	789	716	1,691
Market Cap Growth	-9.59%	-23.06%	80.47%	10.32%	-57.68%	-7.35%
Enterprise Value	1,160	1,089	1,336	704	578	1,487
Last Close Price	19.80	20.35	26.45	15.38	13.87	32.20

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 24, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Forward PE	-	24.15	35.84	72.92	72.92	72.92
PS Ratio	4.14	4.53	6.93	3.68	3.69	8.62
PB Ratio	2.14	3.02	3.20	1.77	1.49	3.05
P/TBV Ratio	2.25	3.15	3.26	1.83	1.56	3.21
P/FCF Ratio	-	-	-	-	-	650.25
P/OCF Ratio	39.08	45.95	-	-	-	38.47

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 24, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	4.50	4.50	6.50	3.28	2.98	7.59
EV/EBITDA Ratio	105.14	107.67	-	81.54	-	53.42
EV/FCF Ratio	-	-	-	-	-	572.04

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 24, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.26	0.05	0.04	0.06	0.06	0.03
Debt / EBITDA Ratio	3.94	0.89	-	1.24	5.92	0.52
Debt / FCF Ratio	-	-	-	-	-	5.74
Net Debt / Equity Ratio	0.19	0.00	-0.13	-0.20	-0.29	-0.38
Net Debt / EBITDA Ratio	3.93	-0.09	4.08	-10.30	53.60	-7.64
Net Debt / FCF Ratio	-1.66	0.03	1.70	2.16	3.57	-81.78
Asset Turnover	0.42	0.48	0.37	0.35	0.29	0.32
Inventory Turnover	2.33	2.41	2.23	2.06	2.15	2.32
Quick Ratio	1.38	1.14	1.90	1.89	1.70	2.95
Current Ratio	1.76	1.62	2.40	2.20	2.04	3.23
Return on Equity (ROE)	24.17%	-19.63%	-7.73%	-6.08%	-7.60%	-2.58%
Return on Assets (ROA)	-0.50%	-3.12%	-5.94%	-2.92%	-3.51%	-1.07%
Return on Invested Capital (ROIC)	-0.63%	-6.68%	-14.24%	-8.12%	-11.09%	-3.17%
Return on Capital Employed (ROCE)	-0.70%	-6.30%	-11.10%	-5.90%	-7.20%	-1.70%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 24, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	10.02%	-7.24%	-2.42%	-3.56%	-5.49%	-0.69%
FCF Yield	-5.31%	-2.79%	-2.40%	-5.21%	-5.40%	0.15%
Dividend Yield	-	-	-	0.52%	0.65%	0.90%
Buyback Yield / Dilution	2.77%	1.35%	-5.48%	-0.04%	-9.32%	-3.74%
Total Shareholder Return	2.77%	1.35%	-5.48%	0.48%	-8.67%	-2.84%

Data Source: S&P Global Market Intelligence Last updated: Sep 16, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 25, 2026

Data Sources Report a data error